Systems, devices and methods for analyte sensor insertion

US12569166B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12569166-B2
Application numberUS-202217667220-A
CountryUS
Kind codeB2
Filing dateFeb 8, 2022
Priority dateJan 23, 2017
Publication dateMar 10, 2026
Grant dateMar 10, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems, devices and methods are provided for inserting at least a portion of an in vivo analyte sensor, such as a dermal sensor, for sensing an analyte level in a bodily fluid of a subject. An applicator is positioned against a skin surface and a force is applied to the applicator causing at least a portion of a sharp and an in vivo analyte sensor to be positioned in the body of the subject. In particular, disclosed herein are embodiments of applicators designed to prevent premature sharp withdrawal and/or reduce the likelihood of improper sensor insertion. Also disclosed are embodiments of applicators including sharp modules having an angled sharp which can be configured to create an insertion path for a sensor.

First claim

Opening claim text (preview).

What is claimed is: 1 . An assembly comprising: an inserter, comprising: a first carrier assembly disposed in an interior of the inserter, the first carrier assembly comprising a sharp configured to insert a portion of a glucose sensor into a subject's body; a retraction spring disposed in the interior of the inserter, the retraction spring comprising a proximal end disposed in an interior of the first carrier assembly; a second carrier assembly comprising one or more proximally-extending carrier arms; and wherein the first carrier assembly further comprises one or more detents configured to detachably engage with the one or more proximally extending carrier arms; wherein the first carrier assembly, the retraction spring, and the second carrier assembly are configured to advance in a distal direction toward the subject's skin from a proximal position entirely in the interior of the inserter to a distal position, wherein engagement of the one or more proximally-extending carrier arms and the one or more detents is configured to prevent relative movement of the first carrier assembly and the second carrier assembly in the proximal position, wherein, after the first carrier assembly, the retraction spring, and the second carrier assembly advance from the proximal position, each proximally-extending carrier arm of the one or more proximally-extending carrier arms is configured to disengage from a corresponding detent of the one or more detents, wherein advancement of the first carrier assembly, the retraction spring, and the second carrier assembly causes insertion of the portion of the glucose sensor into the subject's body, wherein the retraction spring is configured to expand after the insertion of the portion of the glucose sensor into the subject's body, wherein the one or more proximally-extending carrier arms extend through an interior of the retraction spring, wherein the each proximally-extending carrier arm of the one or more proximally-extending carrier arms and the corresponding detent of the one or more detents form a latch, wherein the each proximally-extending carrier arm of the one or more proximally-extending carrier arms is configured to disengage from the corresponding detent of the one or more detents in response to a force applied in a proximal direction to the first carrier assembly. 2 . The assembly of claim 1 , further comprising a sensor control device comprising the glucose sensor coupled with sensor electronics. 3 . The assembly of claim 2 , wherein the sensor control device is configured to be positioned on the subject's skin when the first carrier assembly, the retraction spring, and the second carrier assembly are in the distal position. 4 . The assembly of claim 3 , wherein the each proximally-extending carrier arm of the one or more proximally-extending carrier arms comprises a corresponding laterally-extending retention feature. 5 . The assembly of claim 4 , wherein the corresponding laterally-extending retention feature is disposed on a proximal end of the each proximally-extending carrier arm. 6 . The assembly of claim 4 , wherein the each proximally-extending carrier arm of the one or more proximally-extending carrier arms is configured to prevent expansion of the retraction spring via the corresponding laterally-extending retention feature. 7 . The assembly of claim 3 , wherein at least a part of the glucose sensor is disposed in the sharp when the first carrier assembly, the retraction spring, and the second carrier assembly are in the proximal position. 8 . The assembly of claim 2 , wherein the sensor control device further comprises an adhesive portion configured to secure the sensor control device to the subject's skin. 9 . The assembly of claim 2 , wherein the sensor electronics comprises a processor, memory, a power source, and communication circuitry configured to wirelessly communicate data indicative of a glucose level. 10 . The assembly of claim 2 , wherein the sensor control device further comprises a sensor hub, wherein the portion of the glucose sensor is a part of a distal sensor portion, wherein the glucose sensor comprises the distal sensor portion and a proximal sensor portion, wherein the part of the distal sensor portion is configured to sense a glucose level of the subject, wherein the proximal sensor portion is engaged with the sensor hub, and wherein the distal sensor portion is substantially orthogonal to the proximal sensor portion. 11 . The assembly of claim 1 , wherein the each proximally-extending carrier arm of the one or more proximally-extending carrier arms is biased against the corresponding detent of the one or more detents. 12 . The assembly of claim 1 , wherein the retraction spring comprises a compression spring. 13 . The assembly of claim 12 , wherein the compression spring is in a preloaded, compressed state while the first carrier assembly, the retraction spring, and the second carrier assembly are advanced from the proximal position to the distal position. 14 . The assembly of claim 12 , wherein the compression spring is biased to retract the first carrier assembly in a proximal direction away from the subject's skin. 15 . The assembly of claim 1 , wherein the first carrier assembly, the retraction spring, and the second carrier assembly are further configured to advance along a linear path. 16 . The assembly of claim 1 , further comprising a cap removably attached to the inserter by a plurality of threads, and wherein the cap comprises an interior space comprising a sterile environment. 17 . The assembly of claim 1 , wherein the first carrier assembly is releasably coupled with the second carrier assembly when the first carrier assembly, the retraction spring, and the second carrier assembly are in the proximal position. 18 . The assembly of claim 17 , wherein the first carrier assembly is configured to decouple from the second carrier assembly after the first carrier assembly, the retraction spring, and the second carrier assembly reach the distal position. 19 . The assembly of claim 1 , wherein the retraction spring is configured to apply a second force that retracts the first carrier assembly after the first carrier assembly, the retraction spring, and the second carrier assembly reach the distal position.

Assignees

Inventors

Classifications

  • Modular apparatus · CPC title

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

  • Measuring for diagnostic purposes (radiation diagnosis A61B6/00; diagnosis by ultrasonic, sonic or infrasonic waves A61B8/00); Identification of persons · CPC title

  • characterised by the type of physiological signal transmitted · CPC title

  • Devices specially adapted for delivering implantable medical measuring apparatus · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12569166B2 cover?
Systems, devices and methods are provided for inserting at least a portion of an in vivo analyte sensor, such as a dermal sensor, for sensing an analyte level in a bodily fluid of a subject. An applicator is positioned against a skin surface and a force is applied to the applicator causing at least a portion of a sharp and an in vivo analyte sensor to be positioned in the body of the subject. I…
Who is the assignee on this patent?
Abbott Diabetes Care Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/14503. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).